Appropriate use of antibiotics in hospitals: Investigating clinical practices in management of community-acquired pneumonia;Bon usage des antibiotiques à l'hôpital: Évaluation des pratiques professionnelles de prise en charge des pneumopathies communautaires

Presse Medicale

Volumn 34, Issue 22 I, 2005, Pages 1687-1695

  Navas, D ^a   Caillon, J ^a   Potel, G ^b,c  

^a Pharmacien PH ^*

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; DRUG USE; FEMALE; HOSPITAL MANAGEMENT; HUMAN; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY CONTROL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; WARD;

EID: 33344473101     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)84252-6     Document Type: Article

References (30)

1. Institute of Medicine. In: Clinical practice guidelines: directions for a new agency. Field MY, Lohr KN ed. National Academy Press, Washington DC 1990.
2. Renvoise EB, Hampshaw SM, Pinder JM, Ayres P. What are hospitals doing about clinical guidelines? Quality in Health care 1997; 6: 187-91.
3. Ministère des Affaires Sociales et de l'Intégration. Loi no92-1279 du 8 décembre 1992 modifiant le livre V du code de la santé publique et relative à la pharmacie et au médicament. Journal officiel, 11 décembre 1992: 16888-91.
4. Ministère de l'emploi et de la solidarité. Décret no 2000-1316 du 26 décembre 2000 relatif aux pharmacies à usage intérieur et modifiant le code de la santé publique. Journal officiel, 30 décembre 2000: 20954-63.
5. Agence Nationale pour le Développement de l'Évaluation Médicale (ANDEM). In: Le bon usage des antibiotiques à l'hôpital. Recommandations pour maîtriser le développement de la résistance bactérienne. Editions N. Attali, Août 1996.
6. Ministère de l'emploi et de la solidarité. Circulaire DHOS/E2 - DGS/SD5A no 272 du 2 mai 2002 relative au bon usage des antibiotiques dans les établissements de santé et à la mise en place à titre expérimental de centres de conseil en antibiothé rapie pour les médecins libéraux.
7. Moss FM, McSwiggan DA, McNicol MW, Miller DL. Survey of antibiotic prescribing in a district general hospital. II. Lower respiratory tract infection. Lancet 1981; 2: 407-9.
8. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124: 884-90.
9. Kunin CM. Problems in antibiotic usage. In: Principles and practice of infectious diseases. 3rd ed. Mandell GL, Douglas RG, Benett JE eds. Churchill Livingstone Inc, New York 1990; 427-434.
10. Milatovic D, Bravery I. Development of resistances during antibiotic therapy, Eur J Clin Microbiol 1987; 6: 234-44.
11. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999; 43: 459-65.
12. Société de pathologie infectieuse de langue française (SPILF). 4° conférence de consensus en thérapeutique anti-infectieuse. Lille, 18 octobre 1991. Les infections des voies respiratoires. Med Mal Infect 1991; 21 (suppl. oct): 1-8
13. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
14. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-51.
15. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891-6.
16. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18: 501-15.
17. Société de pathologie infectieuse de langue française (SPILF). Quelle doit être l'antibiothérapie de première intention des pneumonies aiguës communautaires? Quelle doit être sa réévaluation en cas d'échec, compte tenu de l'évolution des agents responsables, des résistances du pneumocoque et cela justifie-t-il des associations ? Med Mal Infect 2001; 31: 344-51.
18. Ehrenkranz NJ, Nerenberg DE, Shultz JM, Slater KC. Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening patient stay. Infect Control Hosp Epidemiol 1992; 13: 21-32.
19. Gilbert K, Gleason PP, Singer DE, Marrie TJ, Coley CM, Obrosky DS et al. Variations in antimicrobial use and cost in more than 2 000 patients with community-acquired pneumonia. Am J Med 1998; 104: 17-27.
20. Wunderink RG. Clinical practice guidelines for the management of pneumonia - Do they work? New Horiz 1998; 6: 75-83.
21. Margolis CZ. Methodology matters - VII. Clinical practice guidelines: methodological considerations. Int J for Quality in Health Care 1997; 9: 303-6.
22. Fein AM, Niederman MS. Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster. Am J Respir Crit Care Med 1995; 152: 1149-53.
23. Davies HT, Crombie IK. Assessing the quality of care. BMJ 1995; 311: 766.
24. Capelastegui A, Espana PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004; 39: 955-63.
25. Weingarten SR, Riedinger MS, Hobson P, Noah MS, Johnson B, Giugliano G et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med 1996; 153: 1110-15.
26. Castro-Guardiola A, Viejo-Rodriguez AL, Soler-Simon S, Armengou-Arxe A, Bisbe-Company V, Penarroja-Matutano G et al. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial. Am J Med 2001; 111: 367-74.
27. Orrick JJ, Segal R, Johns TE, Russell W, Wang F, Yin DD. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines. Pharmacoeconomics 2004; 22: 751-7.
28. Burns LR, Wholey DR. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care 1991; 29: 251-71.
29. Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993; 31: 371-80.
30. McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR, Obrosky DS et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999; 107: 5-12.